These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 16203323)

  • 1. Defining harm reduction.
    Single E
    Drug Alcohol Rev; 1995; 14(3):287-90. PubMed ID: 16203323
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Harm reduction: what it is and is not.
    Erickson PG
    Drug Alcohol Rev; 1995; 14(3):283-5. PubMed ID: 16203322
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A review of the efficacy and effectiveness of harm reduction strategies for alcohol, tobacco and illicit drugs.
    Ritter A; Cameron J
    Drug Alcohol Rev; 2006 Nov; 25(6):611-24. PubMed ID: 17132577
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Charting WHO--goals for licit and illicit drugs for the year 2000: are we 'on track'?
    Fischer B; Kendall P; Rehm J; Room R
    Public Health; 1997 Sep; 111(5):271-5. PubMed ID: 9308373
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The role of law enforcement in minimizing the harm resulting from illicit drugs.
    Hellawell K
    Drug Alcohol Rev; 1995; 14(3):317-22. PubMed ID: 16203327
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Harm reduction programmes in the Asia--Pacific Region.
    Reid G; Devaney ML; Baldwin S
    Drug Alcohol Rev; 2008 Jan; 27(1):95-8. PubMed ID: 18034387
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Improving health and social care relationships for harm reduction.
    Allman D; Myers T; Schellenberg J; Strike C; Cockerill R; Cavalieri W
    Int J Drug Policy; 2007 May; 18(3):194-203. PubMed ID: 17689366
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Setting goals for drug policy: harm reduction or use reduction?
    Caulkins JP; Reuter P
    Addiction; 1997 Sep; 92(9):1143-50. PubMed ID: 9374012
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Groundwork for a research programme on harm reduction in alcohol and drug treatment.
    Heather N
    Drug Alcohol Rev; 1995; 14(3):331-6. PubMed ID: 16203329
    [TBL] [Abstract][Full Text] [Related]  

  • 10. If supply-oriented drug policy is broken, can harm reduction help fix it? Melding disciplines and methods to advance international drug-control policy.
    Greenfield VA; Paoli L
    Int J Drug Policy; 2012 Jan; 23(1):6-15. PubMed ID: 21689918
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impact of joined-up HIV harm reduction and multidrug resistant tuberculosis control programmes in Estonia: System dynamics simulation model.
    Atun RA; Lebcir RM; McKee M; Habicht J; Coker RJ
    Health Policy; 2007 May; 81(2-3):207-17. PubMed ID: 16854499
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Increasing prevalence of HIV, and persistent high-risk behaviours among drug users in Bangladesh: need for a comprehensive harm reduction programme.
    Islam MM; Conigrave KM
    Drug Alcohol Rev; 2007 Jul; 26(4):445-54. PubMed ID: 17564883
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [The issue of harm reduction in Polish legislation concerning drug addiction. A comparative study].
    Sobeyko J
    Ann Acad Med Stetin; 2008; 54(2):119-31. PubMed ID: 19374242
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The development of peer educator-based harm reduction programmes in Northern Vietnam.
    Walsh N; Gibbie TM; Higgs P
    Drug Alcohol Rev; 2008 Mar; 27(2):200-3. PubMed ID: 18264883
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Strengthening drug policy and practice through ethics engagement: an old challenge for a new harm reduction.
    Irwin KS; Fry CL
    Int J Drug Policy; 2007 Mar; 18(2):75-83. PubMed ID: 17689348
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Patterns of use and harm reduction practices of ecstasy users in Australia.
    Allott K; Redman J
    Drug Alcohol Depend; 2006 Apr; 82(2):168-76. PubMed ID: 16226850
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Injecting nation: achieving control of hepatitis C in Australia.
    Wodak A
    Drug Alcohol Rev; 1997 Sep; 16(3):275-84. PubMed ID: 16203436
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Moral regulation and the presumption of guilt in Health Canada's medical cannabis policy and practice.
    Lucas P
    Int J Drug Policy; 2009 Jul; 20(4):296-303. PubMed ID: 19124233
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tobacco harm reduction strategies: the case for physical activity.
    deRuiter W; Faulkner G
    Nicotine Tob Res; 2006 Apr; 8(2):157-68. PubMed ID: 16766410
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Harm reduction, hepatitis C and opioid pharmacotherapy: an opportunity for integrated hepatitis C virus-specific harm reduction.
    Hallinan R; Byrne A; Dore GJ
    Drug Alcohol Rev; 2007 Jul; 26(4):437-43. PubMed ID: 17564882
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.